Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

7.02
Delayed Data
As of Feb 12
 +0.17 / +2.48%
Today’s Change
5.50
Today|||52-Week Range
13.18
-32.89%
Year-to-Date

Today’s Trading

Previous close6.85
Today’s open6.92
Day’s range6.66 - 7.03
Volume359,129
Average volume (3 months)562,742
Market cap$272.7M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+66.94%
Earnings growth (this year)-150.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+53.16%
P/E ratioNM
Price/Sales6.09
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+1.07+7.63%
NUTRNutraceutical Intern...+0.32+1.32%
RIGLRigel Pharmaceutical...+0.07+2.92%
CDTXCidara Therapeutics ...+0.90+9.08%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$46.9M
Annual profit (last year)-$14.6M
Net profit margin-31.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers